A Study to Investigate the Safety, Tolerability & Pharmacokinetics of

See also
Status	Clinical Trial	Phase
Completed	`NCT04090957` - Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women	Phase 3
Completed	`NCT01052454` - Mindfulness-Based Stress Reduction for Hot Flashes	Phase 0
Completed	`NCT00535288` - Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)	Phase 3
Recruiting	`NCT00906308` - A Study of MF101 in Postmenopausal Women	Phase 3
Completed	`NCT01452373` - Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women	Phase 3
Completed	`NCT00560833` - Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012)	Phase 3
Completed	`NCT05033886` - A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause	Phase 3
Completed	`NCT05083884` - A Survey About Hot Flashes in Women Going Through the Menopause
Completed	`NCT01178892` - MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation	N/A
Completed	`NCT00397176` - Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women	Phase 1
Recruiting	`NCT06122181` - Study of HS-10384 in Participants of Chinese Postmenopausal Women	Phase 1
Not yet recruiting	`NCT06393673` - A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women	Phase 2
Withdrawn	`NCT02202707` - Vasomotor Symptoms and Cardiovascular Control	N/A
Completed	`NCT00356447` - Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.	Phase 3
Completed	`NCT05312567` - FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms	Phase 2
Terminated	`NCT01353963` - Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients	Phase 4
Completed	`NCT00446199` - Low-dose Hormone Therapy for Relief of Vasomotor Symptoms	Phase 3
Completed	`NCT05850338` - Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women	N/A
Completed	`NCT00683800` - Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women	Phase 3
Completed	`NCT03512002` - HIRREM Hot Flashes Study	N/A

NCT number	NCT02803268
Study type	Interventional
Source	Mitsubishi Tanabe Pharma Corporation
Contact
Status	Completed
Phase	Phase 1
Start date	June 2016
Completion date	January 2017

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms